Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun;61(6):87-91.
doi: 10.1136/dtb.2022.000050. Epub 2023 May 16.

Increasing trend in hospitalisation due to adverse drug reactions: can we stem the tide?

Affiliations
Review

Increasing trend in hospitalisation due to adverse drug reactions: can we stem the tide?

Lauren E Walker et al. Drug Ther Bull. 2023 Jun.

Abstract

Living with multiple long-term health conditions (multimorbidity) is increasingly common in older age. The more long-term conditions that an individual has, the more medicines they are likely to take. Hospitalisation as a consequence of medication-related harm is increasing and a concerted effort is needed to reduce the burden of harm caused by medication. However, making decisions about the balance between benefit and harm for an older person with multimorbidity and polypharmacy is very complex. There are various clinical tools that can help to identify patients at higher risk of harm and numerous strategies, including medicines optimisation reviews that incorporate personalised health information, to try to reduce risk. Further education and training of the healthcare professionals is needed to equip the multidisciplinary workforce with the skills and knowledge to address these challenges. This article discusses some of the changes that can be implemented now and highlights areas that will require more research before they can be introduced, in order to help patients to get the best out of their medicines.

Keywords: Drug interactions; Drug-Related Side Effects and Adverse Reactions; Polypharmacy; Therapeutics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared. Refer to the online supplementary files to view the ICMJE form(s).

MeSH terms

LinkOut - more resources